Needham & Company
-
Pre-Open Stock Movers 04/01: (CSII) (VJET) (TSLA) Higher; (BBRY) (SUNE) (GNCA) Lower (more...)
-
Isis Pharmaceuticals to Present at Upcoming Investor Conferences
-
PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
-
Streetinsider.com's Hot Lunchtime Reads 03/18: (INCY) (ISRG) (NXPI) (GOOG) (DIS)
-
Needham & Company Maintains a 'Hold' on Watson Pharmaceuticals (WPI); FDA Approves Amphastar’s Long Forgotten ANDA for Generic Lovenox
-
Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); TEVA Comes Through With Allegra OTC Approval, “In Numbers” but Should Provide Additional Fuel
-
Needham & Company Maintains a 'Hold' on ISIS Pharmaceuticals (ISIS); Pipeline Progress Review – Long-Term, Early Stage Programs Are Encouraging
-
Needham & Company Reiterates a 'Buy' on Vical, Inc. (VICL); Encouraging Phase 2 TransVax Data Presented at ICAAC
-
Notable Analyst Rating Changes 08/30: SNY, RTN, NBL, CAVM Upgraded; LMT, LULU, TXN, AZO Downgrade
-
Notable 52-Week High's and Low's of the Day 07/23: RVBD, ARMH, GENZ, INFA, NXTM High; GAP, BEC, WDC, YHOO Low

